Publicaciones en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (11)

2024

  1. Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders

    Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389

2022

  1. Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

    European Neuropsychopharmacology, Vol. 54, pp. 90-99

2021

  1. Corrigendum to “Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]” (European Neuropsychopharmacology (2020) 36 (121–136), (S0924977X20301802), (10.1016/j.euroneuro.2020.05.006))

    European Neuropsychopharmacology

  2. DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network

    European Neuropsychopharmacology, Vol. 47, pp. 54-61

2020

  1. Copy-number alteration burden differentially impacts immune profiles and molecular features of hepatocellular carcinoma

    Clinical Cancer Research, Vol. 26, Núm. 23, pp. 6350-6361

  2. Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action

    European Neuropsychopharmacology, Vol. 36, pp. 121-136

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

2014

  1. Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study

    BMC Nephrology, Vol. 15, Núm. 1

2013

  1. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

    Nature Genetics, Vol. 45, Núm. 8, pp. 868-876

  2. The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    American Journal of Psychiatry, Vol. 170, Núm. 11, pp. 1249-1262

2006

  1. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory

    Journal of Neuroscience, Vol. 26, Núm. 7, pp. 1923-1934